Projects funded by the NCN
Integrity of E3 ubiquitin ligase complex as a biomarker of response to treatment with immunomodulatory drugs in patients with multiple myeloma.
2014/13/B/NZ5/03160
Keywords:
cereblone thalidomide lenalidomide multiple myeloma
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_7: Human disease treatment
- NZ5_9: Other related subjects
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Hematologii i Transfuzjologii
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 7 - announced on 2014-03-17
Amount awarded: 403 084 PLN
Project start date (Y-m-d): 2015-02-25
Project end date (Y-m-d): 2018-02-24
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Information in the final report
- Publication in academic press/journals (1)
- Articles in post-conference publications (1)
- The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma PatientsAuthors:Joanna Barankiewicz; Anna Szumera-Ciećkiewicz; Aleksander Salomon-Perzyński; Paulina Wieszczy; Agata Malenda; Filip Garbicz; Monika Prochorec-Sobieszek; Irena Misiewicz-Krzemińska; Przemysław Juszczyński; Ewa Lech-MarańdaAcademic press:Jounral of Clinical Medicine (rok: 2021, tom: 10, strony: 10(12):2683.), Wydawca: MDPIStatus:PublishedDOI:10.3390/jcm10122683 - link to the publication
- EXPRESSION SIGNIFICANCE OF CRL4-CRBN PROTEINS COMPLEX IN MULTIPLE MYELOMA PATIENTS TREATED WITH IMMUNOMODULATORY DRUGS.Authors:Joanna Barankiewicz, Agata Malenda, Filip Garbicz, Anna Szumera-Ciećkiewicz, Monika Prochorec-Sobieszek, Przemysław Juszczyński, Ewa Lech-MarańdaConference:European Hematology Association Virtual Congress (rok: 2020, ), Wydawca: EHA LibraryData:konferencja 18.06 - 15.08.2020Status:Published